verified SJR 2,202 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed

United Kingdom · BioMed Central Ltd

workspace_premium Q1 — Oncology verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Breast Cancer Research

Breast Cancer Research is a journal indexed in SJR in Oncology and Cancer Research with an H index of 182. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2890 €. The scope of the journal is focused on oncology, breast cancer. It has an SJR impact factor of 2,202 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,202.

Breast Cancer Research focuses its scope in these topics and keywords: breast, cancer, tumor, receptor, metastasis, estrogen, intravasation, collageni, community, extracellular, ...

ISSN: 1465-5411

Publisher: BioMed Central Ltd

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

2,202 Q1

H-index 182

Acceptance rate pie_chart

21% Selective

Source Acceptance_Rate

Time to publication hourglass_top

12 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

2.890 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

2,202

H-index

182

Docs (year)

186

Docs 3y

357

Total refs

9224

Cites 3y

2047

Citable 3y

352

Cites/Doc 2y

5.33

Ref/Doc

49.59

Immediate OA

2890 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Mammographic texture resemblance generalizes as an independent risk factor for breast cancer

Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study

Trastuzumab emtansine: mechanisms of action and drug resistance

Smoking at time of diagnosis and breast cancer-specific survival: new findings and systematic review with meta-analysis

Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects

Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions

Relationships between computer-extracted mammographic texture pattern features and

Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer

P8-03: Exact quantification of gene amplification in archival tissue sections by laser-assisted microdissection and real-time PCR

Outsmarting cancer: the power of hybrid genomic/proteomic biomarkers to predict drug response

New insights into the role of ID proteins in breast cancer metastasis: a MET affair

SHOW MORE ARTICLES

N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma

Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters

A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue

Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer

In silico analysis of microRNA-510 as a potential oncomir in human breast cancer

Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening

Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor beta1 signaling in metastatic breast cancers

Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation

Effects of an exercise and hypocaloric healthy eating intervention on indices of psychological health status, hypothalamic-pituitary-adrenal axis regulation and immune function after early-stage breast cancer: a randomised controlled trial

Early but not late pregnancy induces lifelong reductions in the proportion of mammary progesterone sensing cells and epithelial Wnt signaling

Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients

FAQs

Breast Cancer Research has an SJR of 2,202 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2890 EUR.

The acceptance rate recorded for Breast Cancer Research is 21%.

Breast Cancer Research

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Breast Cancer Research?

What is the APC / publication cost?

What is the acceptance rate?